This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
In a national settlement, Oregon and other states pushed the overall figure up to $6 billion for the company’s role in the opioid crisis.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The state and local governments can’t agree on how the money should be allocated, putting the total amount available to Oregon in jeopardy.
Legal officials in Oregon and Washington said their states have not agreed to a reported $12 billion settlement reached Wednesday between some 2,000 local and state governments and Purdue Pharma, the maker of OxyContin.
